- April 8, 2016
The Bad – Risks & Complications
Risks and complications associated with inpatient glucose control spark some of the most dreaded conversations exchanged in healthcare. Clinicians are accustomed with these situations, and would prefer little, or rather, no occurrence. The detrimental obstacles include:
- Hyperglycemia – high blood sugar in hospitalized patients is common and associated with increased risk of infection, mortality, and escalated cost.
- Hypoglycemia – low blood sugar in hospitalized patients is the most common acute adverse effect of glucose-lowering therapy among patients with diabetes mellitus. Hypoglycemia is also associated with poor outcomes.
- Poor treatment and/or lack of control – poor glucose management is directly linked to higher hyperglycemia and hypoglycemia rates, and poor manifestation of glucose control leading to lower reimbursements, poor outcomes, and mortality.
- Hospital Acquired Conditions (HACs) – manifestations of poor glycemic control include: diabetic ketoacidosis (DKA), nonketotic hyperosmolar coma, hypoglycemic coma, secondary diabetes with ketoacidosis, and secondary diabetes with hyperosmolarity.
After all of that negative information, there is a silver lining. In our upcoming blogs we will discuss the ADA and Joint Commission guidelines towards best practices, as well as “the good” with inpatient glucose control.
Stay tuned for more of the Inpatient Glucose Management Infographic, or, download the infographic today to view!